323 related articles for article (PubMed ID: 15289563)
1. Attenuated virulence and protective efficacy of a Burkholderia pseudomallei bsa type III secretion mutant in murine models of melioidosis.
Stevens MP; Haque A; Atkins T; Hill J; Wood MW; Easton A; Nelson M; Underwood-Fowler C; Titball RW; Bancroft GJ; Galyov EE
Microbiology (Reading); 2004 Aug; 150(Pt 8):2669-2676. PubMed ID: 15289563
[TBL] [Abstract][Full Text] [Related]
2. An Inv/Mxi-Spa-like type III protein secretion system in Burkholderia pseudomallei modulates intracellular behaviour of the pathogen.
Stevens MP; Wood MW; Taylor LA; Monaghan P; Hawes P; Jones PW; Wallis TS; Galyov EE
Mol Microbiol; 2002 Nov; 46(3):649-59. PubMed ID: 12410823
[TBL] [Abstract][Full Text] [Related]
3. BPSS1504, a cluster 1 type VI secretion gene, is involved in intracellular survival and virulence of Burkholderia pseudomallei.
Hopf V; Göhler A; Eske-Pogodda K; Bast A; Steinmetz I; Breitbach K
Infect Immun; 2014 May; 82(5):2006-15. PubMed ID: 24595140
[TBL] [Abstract][Full Text] [Related]
4. Characterization of BPSS1521 (bprD), a regulator of Burkholderia pseudomallei virulence gene expression in the mouse model.
Chirakul S; Bartpho T; Wongsurawat T; Taweechaisupapong S; Karoonutaisiri N; Talaat AM; Wongratanacheewin S; Ernst RK; Sermswan RW
PLoS One; 2014; 9(8):e104313. PubMed ID: 25111708
[TBL] [Abstract][Full Text] [Related]
5. Evaluating Burkholderia pseudomallei Bip proteins as vaccines and Bip antibodies as detection agents.
Druar C; Yu F; Barnes JL; Okinaka RT; Chantratita N; Beg S; Stratilo CW; Olive AJ; Soltes G; Russell ML; Limmathurotsakul D; Norton RE; Ni SX; Picking WD; Jackson PJ; Stewart DI; Tsvetnitsky V; Picking WL; Cherwonogrodzky JW; Ketheesan N; Peacock SJ; Wiersma EJ
FEMS Immunol Med Microbiol; 2008 Jan; 52(1):78-87. PubMed ID: 17995960
[TBL] [Abstract][Full Text] [Related]
6. Inactivation of Burkholderia pseudomallei bsaQ results in decreased invasion efficiency and delayed escape of bacteria from endocytic vesicles.
Muangsombut V; Suparak S; Pumirat P; Damnin S; Vattanaviboon P; Thongboonkerd V; Korbsrisate S
Arch Microbiol; 2008 Dec; 190(6):623-31. PubMed ID: 18654761
[TBL] [Abstract][Full Text] [Related]
7. Functional characterizations of effector protein BipC, a type III secretion system protein, in Burkholderia pseudomallei pathogenesis.
Kang WT; Vellasamy KM; Chua EG; Vadivelu J
J Infect Dis; 2015 Mar; 211(5):827-34. PubMed ID: 25165162
[TBL] [Abstract][Full Text] [Related]
8. Systematic mutagenesis of genes encoding predicted autotransported proteins of Burkholderia pseudomallei identifies factors mediating virulence in mice, net intracellular replication and a novel protein conferring serum resistance.
Lazar Adler NR; Stevens MP; Dean RE; Saint RJ; Pankhania D; Prior JL; Atkins TP; Kessler B; Nithichanon A; Lertmemongkolchai G; Galyov EE
PLoS One; 2015; 10(4):e0121271. PubMed ID: 25830295
[TBL] [Abstract][Full Text] [Related]
9. Inactivation of bpsl1039-1040 ATP-binding cassette transporter reduces intracellular survival in macrophages, biofilm formation and virulence in the murine model of Burkholderia pseudomallei infection.
Pinweha P; Pumirat P; Cuccui J; Jitprasutwit N; Muangsombut V; Srinon V; Boonyuen U; Thiennimitr P; Vattanaviboon P; Cia F; Willcocks S; Bancroft GJ; Wren BW; Korbsrisate S
PLoS One; 2018; 13(5):e0196202. PubMed ID: 29771915
[TBL] [Abstract][Full Text] [Related]
10. Correlates of immune protection following cutaneous immunization with an attenuated Burkholderia pseudomallei vaccine.
Silva EB; Goodyear A; Sutherland MD; Podnecky NL; Gonzalez-Juarrero M; Schweizer HP; Dow SW
Infect Immun; 2013 Dec; 81(12):4626-34. PubMed ID: 24101688
[TBL] [Abstract][Full Text] [Related]
11. A mutant of Burkholderia pseudomallei, auxotrophic in the branched chain amino acid biosynthetic pathway, is attenuated and protective in a murine model of melioidosis.
Atkins T; Prior RG; Mack K; Russell P; Nelson M; Oyston PC; Dougan G; Titball RW
Infect Immun; 2002 Sep; 70(9):5290-4. PubMed ID: 12183585
[TBL] [Abstract][Full Text] [Related]
12. Production and purification of Burkholderia pseudomallei BipD protein.
Visutthi M; Jitsurong S; Chotigeat W
Southeast Asian J Trop Med Public Health; 2008 Jan; 39(1):109-14. PubMed ID: 18567449
[TBL] [Abstract][Full Text] [Related]
13. Burkholderia thailandensis as a model system for the study of the virulence-associated type III secretion system of Burkholderia pseudomallei.
Haraga A; West TE; Brittnacher MJ; Skerrett SJ; Miller SI
Infect Immun; 2008 Nov; 76(11):5402-11. PubMed ID: 18779342
[TBL] [Abstract][Full Text] [Related]
14. Type III Secretion in the Melioidosis Pathogen
Vander Broek CW; Stevens JM
Front Cell Infect Microbiol; 2017; 7():255. PubMed ID: 28664152
[No Abstract] [Full Text] [Related]
15. Characterisation of an acapsular mutant of Burkholderia pseudomallei identified by signature tagged mutagenesis.
Atkins T; Prior R; Mack K; Russell P; Nelson M; Prior J; Ellis J; Oyston PCF; Dougan G; Titball RW
J Med Microbiol; 2002 Jul; 51(7):539-553. PubMed ID: 12132769
[TBL] [Abstract][Full Text] [Related]
16. Quantitative proteomic analysis of Burkholderia pseudomallei Bsa type III secretion system effectors using hypersecreting mutants.
Vander Broek CW; Chalmers KJ; Stevens MP; Stevens JM
Mol Cell Proteomics; 2015 Apr; 14(4):905-16. PubMed ID: 25635268
[TBL] [Abstract][Full Text] [Related]
17. Role for the Burkholderia pseudomallei type three secretion system cluster 1 bpscN gene in virulence.
D'Cruze T; Gong L; Treerat P; Ramm G; Boyce JD; Prescott M; Adler B; Devenish RJ
Infect Immun; 2011 Sep; 79(9):3659-64. PubMed ID: 21768285
[TBL] [Abstract][Full Text] [Related]
18. The Burkholderia pseudomallei Proteins BapA and BapC Are Secreted TTSS3 Effectors and BapB Levels Modulate Expression of BopE.
Treerat P; Alwis P; D'Cruze T; Cullinane M; Vadivelu J; Devenish RJ; Prescott M; Adler B; Boyce JD
PLoS One; 2015; 10(12):e0143916. PubMed ID: 26624293
[TBL] [Abstract][Full Text] [Related]
19. A novel FK-506-binding-like protein that lacks peptidyl-prolyl isomerase activity is involved in intracellular infection and in vivo virulence of Burkholderia pseudomallei.
Norville IH; Breitbach K; Eske-Pogodda K; Harmer NJ; Sarkar-Tyson M; Titball RW; Steinmetz I
Microbiology (Reading); 2011 Sep; 157(Pt 9):2629-2638. PubMed ID: 21680634
[TBL] [Abstract][Full Text] [Related]
20. A Burkholderia pseudomallei deltapurM mutant is avirulent in immunocompetent and immunodeficient animals: candidate strain for exclusion from select-agent lists.
Propst KL; Mima T; Choi KH; Dow SW; Schweizer HP
Infect Immun; 2010 Jul; 78(7):3136-43. PubMed ID: 20404077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
